Do patients with empyema really need a VATS?
Topic overview
Institutional experience demonstrates that primary fibrinolysis with tPA has reduced the need for VATS decortication in pediatric empyema to near zero (0% in final 33 months). By raising the threshold for surgical intervention and maximizing nonoperative measures, most children avoid operation without increased hospital stay.
Key takeaways
- Primary fibrinolysis with tPA is effective for pediatric empyema, reducing VATS decortication rate to 0% over 33 months in this series.
- Median treatment course: 5 days chest tube, 3 doses tPA, 8-day hospital stay without need for surgical intervention in 95.8% of cases.
- Raising threshold for VATS and optimizing nonoperative management avoids surgery in most children without prolonging hospitalization.
- Chest tube replacement (14.6% of patients) can successfully manage treatment failures without progressing to operative decortication.
- Primary VATS is unnecessary—fibrinolytic therapy should be first-line treatment for pediatric empyema per this institutional protocol.
Comments